AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. J.
Right arrow Articles by Oh, K. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2683
AJR 2008; 190:476-480
© American Roentgen Ray Society


Original Research

Role of Sonography in the Detection of Contralateral Metachronous Breast Cancer in an Asian Population

Min Jung Kim1, Eun-Kyung Kim1, Jin Young Kwak1, Byeong-Woo Park2, Seung-Il Kim2, Joohyuk Sohn3 and Ki Keun Oh1

1 Department of Diagnostic Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seodaemun-ku Shinchon-dong 134, Seoul 120-752, South Korea.
2 Department of General Surgery, Yonsei University College of Medicine, Seoul, South Korea.
3 Department of Oncology, Yonsei University College of Medicine, Seoul, South Korea.

OBJECTIVE. This study was undertaken to retrospectively assess the contribution of sonographic surveillance in the early detection of metachronous contralateral breast cancer.

MATERIALS AND METHODS. We retrospectively reviewed the pathologic, mammographic, and sonographic records of 51 patients with surgically proven metachronous bilateral breast cancer in 2,498 surgically proven breast cancers during 2000–2006. We first evaluated cancer staging according to the method of detection used to identify metachronous breast cancers. The sensitivity of imaging studies to identify the lesions was also assessed. We compared cancer staging on the basis of whether the patient was included in a screened group, which was one in which a mammogram and sonogram were obtained within 12 months of the pathologic diagnosis of metachronous cancer. Within the screened group, we compared cancer staging on the basis of whether a screening sonogram was obtained within 6 months of the diagnosis of metachronous cancer.

RESULTS. The staging of metachronous cancers showed no statistically significant differences related to detection method. The sensitivity of sonography was 94% and of mammography was 80% in the detection of metachronous cancers. The cancer stage in the screened group was 0 or stage I in 81% and that in the unscreened group was stage II or III in 71% (p < 0.05). Among the screened group, no significant difference was seen in staging regardless of whether a screening sonogram was obtained in the 6 months after diagnosis of metachronous cancer (p = 0.576).

CONCLUSION. Sonography alone detected 14% of metachronous contralateral breast cancers. The results of this study suggest that annual additional sonography with mammography contributes to the early detection of metachronous cancers. However, sonography every 6 months is unlikely to be helpful for the early detection of metachronous cancer.

Keywords: breast cancer • breast cancer screening • breast sonography • women's imaging


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Roentgen Ray Society.